TE Asia to invest in Beacon Hospital

KUALA LUMPUR – TE Asia Healthcare Partners (TE Asia) will acquire a significant stake in Beacon Hospital. This is in line with its strategy in establishing single-specialty hospitals that bring clinician expertise and healthcare operators together.

TE Asia is a leading private healthcare investment and operations platform whereas Beacon Hospital is Malaysia’s leading oncology specialist hospital.

“The healthcare landscape is changing. Patients are becoming more sophisticated and proactive in exploring options for their needs. As medicine grows increasingly complex, healthcare needs to cater to more specific and specialised demands.

“To better fulfill such needs, we are further expanding our Integrated Oncology Centres (IOC) regional portfolio with Beacon Hospital onboard,” said Eng Aik Meng, group chief executive officer of TE Healthcare.

Beacon Hospital is a multidisciplinary hospital with a focus on oncology treatments. It recently received re-accreditation as a European Society for Medical Oncology (ESMO) Designated Centre of Integrated Oncology and Palliative Care and is the first hospital in Malaysia to do so.

TE Healthcare’s IOC portfolio now includes seven oncology centres and more than 40 oncologists across Indonesia, Hong Kong, Philippines, Vietnam, and Malaysia. By coordinating resources, sharing best practices, and tapping on economies of scale, IOC benefits both doctors and patients.

Compared to traditional multi-specialty healthcare, single-specialty hospitals offer the advantages of specialisation, reduce operational costs, require less capital, and more importantly, improve patient accessibility.

“Our doctors are our partners and hence involved in all major decisions. The IOC platform enables doctors to focus on a particular set of diseases and be assured of access to capital and operational & management expertise. With this, we expect to provide better outcomes to all our patients,” Aik Meng added.

“We remain committed to offering the same, if not better, high-quality treatments to patients under our corporate social responsibility (CSR) programme, which has subsidised more than RM32 million of treatment costs for the under-privileged since 2011,” said Mary Chen, managing director of Beacon Hospital.

Other than Beacon Hospital and HSC Medical Centre, TE Asia Healthcare Platform’s portfolio in Malaysia includes Cardiac Vascular Sentral KL. – The Vibes, December 12, 2020